The Effect Of First Trimester Screening Markers On Intrauterine Growth Retardation And On Poor Neonatal Outcome

Yıl 2018, Cilt: 15 Sayı: 2, 61 - 65, 01.04.2018

Yusuf Madendağ İlknur Çöl Madendağ Nuri Danışman

Öz

Aim: Early identification of trisomy 21 can be achieved by investigating fetal nuchal translucency NT , free human chorionic gonadotropin-β free-βhCG and pregnancy-associated plasma protein PAPP-A levels in first trimester. With this test, perinatal risks such as other chromosomal anomalies, intrauterine growth retardation IUGR and preterm labor can be determined. Our aim was to investigate whether first trimester test markers were successful in predicting IUGR. In addition, another aim was to reveal using these markers whether success of prediction of poor pregnancy outcome in patients with IUGR.Material and Methods: This study was done in an university hospital, retrospectively, with two group IUGR and healthy groups . Patients in both groups were delivered between 36-41th gestational weeks and performed first trimester screening test.Results: A total of 184 pregnant women were reached, 85 were IUGR, while 99 were healthy pregnant control group. When the first trimester screening test parameters were compared, PAPP-A and free β-hCG were found to be statistically significant decline in the IUGR group compared with controls p=0.019, p=0.037, respectively . However only low PAPP-A level was found to be significant after age and smoking and weight correction was done statistically.Conclusion: In summary, the first trimester low serum PAPP-A level may indicate IUGR which may occur during the late period of pregnancy. None of the markers used in the first trimester screening test on the poor neonatal outcome were successful.

Anahtar Kelimeler

Intrauterine growth retardation, first trimester screening test, - PAPP-A, β-hCG

Birinci Trimester Tarama Testi Belirteçlerinin İntrauterin Gelişme Geriliği İle İlişkisi ve Neonatal Sonuçları Üzerine Etkisi

Öz

Giriş: Birinci trimesterde fetal nuchal translucency NT , free human chorionic gonadotropin-β free-βhCG ve pregnancy-associated plasma protein-A PAPP-A değerlerini araştırarak, trizomi-21’in erken tanısında tanıma sağlanabilir. Bu test ile diğer kromozomal anomaliler, intrauterin gelişme geriliği IUGG ve preterm eylem gibi perinatal riskler de belirlenebilir. Amacımız, IUGG tanısı alıp birinci trimester tarama testlerine ulaşabildiğimiz gebelerin postpartum sonuçları ile test sonuçlarını karşılaştırarak, IUGG’ nin önceden tahmininin mümkün olup olmadığını araştırmaktır. Ayrıca yine bu markerleri kullanarak IUGG’li gebelerde kötü perinatal sonucun önceden tahmin edebilme başarısını ortaya koymaktır.Gereç ve Yöntemler: Bu çalışma retrospektif olarak 2 yıllık bir zaman diliminde, bir eğitim ve araştırma hastanesinde yapıldı. Veritabanı ve hasta dosyalarında tetkikler sonrası IUGG tanısı koyulan ve bunlardan birinci trimester tarama testlerine ulaşabildiğimiz, gebelik haftası 36-41 arasında doğum yapanlar çalışma grubunu, ayrıca sağlıklı gebeliğin ardından 36-41 haftalar arasında sağlıklı bebek dünyaya getiren ve tarama testlerine ulaşabildiğimiz gebeler de kontrol grubunu oluşturdu.Bulgular: Toplam 184 gebe bilgilerine ulaşıldı, 85’i IUGG iken, buna karşılık 99’i sağlıklı gebe kontrol grubu olarak değerlendirildi. Birinci trimester tarama testi parametreleri karşılaştırıldığında, ortalama PAPP-A değeri kontrol grubunda hasta grubuna göre daha yüksekti p=0.019 . Free β-hCG de kontrol grubunda daha yüksekti p=0.037 . Gruplar arasındaki kilo, yaş ve sigara farkı için gerekli düzeltmeler yapıldıktan sonra sadece PAPP-A anlamlı bulundu. Test belirteçlerinin IUGG’de kötü neonatal sonucu öngörme başarısı ise anlamsızdı.Sonuç: Özet olarak belirtirsek birinci trimester düşük serum PAPP-A seviyesi gebeliğin geç döneminde ortaya çıkabilecek IUGG’ni yüksek oranda önceden işaret edebilir. Kötü neonatal sonucu öngörmede ise birinci trimester tarama testinde kullanılan belirteçlerin hiçbiri başarılı olamadı.

Anahtar Kelimeler

İntrauterin gelişme geriliği, birinci trimester tarama testi, PAPP-A, β-hCG

Kaynakça

• Zeitlin J, El Ayoubi M, Jarreau PH, Draper ES, Blondel B, Künzel W et al. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. The Journal of pediatrics 2010;157:733-39.
• Nicolaides KH. Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities. Am J Obstet Gynecol 2004;191: 45-67.
• Onderoglu LS, Kabukcu A. Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome. Int J Gynecol Obstet 1997;56:245-9.
• Gonen R, Perez R, David M, Dar H, Merksamer R, Sharf M. The associati- on between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992;80:83-6.
• Yaron Y, Heifetz S, Ochshorn Y, Lehavi O, Urtreger A. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenatal Diagnosis 2002;22:778-82
• Bartha JL, Romero-Carmona R, Escobar-Llompart M, Paloma-Castro O,Comino-Delgado R. Human chorionic gonadotropin and vascular endo- thelial growth factor in normal and complicated pregnancies. Obstetrics & Gynecology 2003;102: 995-99.
• Morssink LP, Kornman LH, Hallahan TW, Kloosterman MD, Beekhuis JR, de Wolf BT et al. Maternal serum levels of free beta-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery. Prenat Diagn 1998;18:147–52
• Pedersen JF, Sorensen S, Ruge S. Human placental lactogen and preg- nancy- associated plasma protein A in first trimester and subsequent fetal growth. Acta Obstet Gynecol Scand 1995;74:505–8
• Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000;107:1265–70
• Smith GC, Stenhouse EJ, Crossley JA, Aitken DA, Cameron AD, Connor JM. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrinol Metab. 2002;87:1762-7.
• Yaron Y, Ochshorn Y, Heifetz S, Lehavi O, Sapir Y, Orr-Urtreger A.First tri- mester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn Ther 2002;17:352-6
• Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan TW et al. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-asso- ciated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol 2004;191:1452-8
• Wide M, Persson H, Lundkvist O, Wide L. Localization of mRNA for the beta-subunit of placental hCG by in situ hybridization. Acta Endocrinol (Copenh) 1998;119:69–74
• Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jen- sen L et al. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 1994;71:560–6
• Lawrence JB, Oxvig C, Overgaard HT, Sottrup-Jencen L, Gleich GJ, Hay SLG et all.The insulin-binding growth factor dependent insulin-binding growth factor binding protein-4 protease secreted by human fibroblasts is PAPP-A. Proc’Natl Acad Sci 1999; 96:3149-53
• Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol 1998;140:19–24
• van Kleffens M, Groffen C, Lindenbergh-Kortleve DJ, van Neck JW, Gonzalez-Parra S, Dits N et al. The IGF system during fetal-placental development of the mouse. Mol Cell Endocrinol 1998;140:129–135
• Kniss DA, Shubert PJ, Zimmerman PD, Landon MB, Gabbe SG .Insulinlike growth factors. Their regulation of glucose and amino acid transport in placental trophoblasts isolated from first-trimester chorionic villi. J Reprod Med 1994;39:249–56
• Irwin JC, Suen LF, Martina NA, Mark SP, Giudice LC Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum Reprod 1990;14:90–6.